Biotech Basics: Drug Pricing

Educational content for biotech investing

Drug pricing in the US is not a straightforward process. For the most part, this is done by design. Politicians and media have put the blame on “evil big pharma” who charge exorbitant prices. The reality, however, is that drug pricing is excessively high due to the complexity of the supply chain. Pharma manufacturers are only a fragment of this chain, t…